CSIMarket
 
Chemed Corporation  (NYSE: CHE)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Chemed's Suppliers Performance

CHE's Supply Chain




 
CHE Costs vs Sales of Suppliers Growth Chemed recorded an increase in cost of sales by 4.07 % year on year, sequentially cost of sales grew by 2.27 % in Q2.

More on CHE Suppliers



Chemed recorded increase in cost of sales by 4.07 % year on year, sequentially cost of sales grew by 2.27 % in Q2.

More on CHE Suppliers




Chemed's Comment on Supply Chain


VITAS maintains relationships with suppliers such as pharmacies, ambulance services, and medical equipment companies, which may refer patients to VITAS and receive referrals in return. The company seeks regulatory guidance to ensure compliance with anti-kickback laws and generally believes its contracts do not violate these laws, although it cannot guarantee how future interpretations may apply. VITAS also addresses HIPAA anti-fraud provisions and monitors enforcement actions by the Office of Inspector General related to healthcare fraud, including hospice-related audits and reviews. In 2017, VITAS entered into a settlement agreement with the Department of Justice concerning False Claims Act litigation and subsequently agreed to a corporate integrity agreement to enhance compliance with federal healthcare program requirements.

Chemed's Comment on Supply Chain


VITAS maintains relationships with suppliers such as pharmacies, ambulance services, and medical equipment companies, which may refer patients to VITAS and receive referrals in return. The company seeks regulatory guidance to ensure compliance with anti-kickback laws and generally believes its contracts do not violate these laws, although it cannot guarantee how future interpretations may apply. VITAS also addresses HIPAA anti-fraud provisions and monitors enforcement actions by the Office of Inspector General related to healthcare fraud, including hospice-related audits and reviews. In 2017, VITAS entered into a settlement agreement with the Department of Justice concerning False Claims Act litigation and subsequently agreed to a corporate integrity agreement to enhance compliance with federal healthcare program requirements.







CHE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Chemed Corporation 6,609.20 2,595.00 274.99 15,811
SUBTOTAL 0.00 0.00 0.00 -


Sources: Chemed Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Chemed Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.